AFMD - Affimed N.V.
IEX Last Trade
1.09
0 0%
Share volume: 4,787
Last Updated: Mon 13 Jan 2025 08:29:55 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.44%
PREVIOUS CLOSE
CHG
CHG%
$1.09
0.00
0.00%
Summary score
22%
Profitability
19%
Dept financing
15%
Liquidity
68%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-22.12%
Return on assets
-12.52%
Return on sales
0%
Return on invested capital
301.82%
Total debt ratio
39.91%
Debt ratio change over timeo
-0.64%
Current Ratio
5%
Quick Ratio
4.97%
Cash Position Ratio
4.2%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-34.85%
Return on assets
-11.48%
Return on sales
0%
Return on invested capital
41.75%
Total debt ratio
66.85%
Debt ratio change over timeo
0.6%
Current Ratio
2.81%
Quick Ratio
2.8%
Cash Position Ratio
2.43%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-29.63%
Return on assets
-11.02%
Return on sales
0%
Return on invested capital
45.43%
Total debt ratio
59.96%
Debt ratio change over time
1.07%
Current Ratio
2.93%
Quick Ratio
2.91%
Cash Position Ratio
2.6%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-121.46%
Return on assets
-110.36%
Return on sales
0%
Return on invested capital
75.52%
Total debt ratio
-64.41%
Debt ratio change over time
-0.64%
Current Ratio
2.69%
Quick Ratio
2.67%
Cash Position Ratio
2.27%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | AFMD | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | -22.12% | -3.05% | 11.55% | 7.11% |
| Return on assets | -12.52% | 3.6% | 3.57% | 3.64% |
| Return on sales | 0% | 32.14% | 42.16% | 21.99% |
| Return on invested capital | 301.82% | 5.09% | 7.99% | 1979.27% |
| Profitability | 4% | 44% | 75% | 78% |
| Total debt ratio | 39.91% | 101.18% | 74.11% | 38.48% |
| Debt ratio change over time | -0.64% | 6.09% | 6.03% | 0.44% |
| Dept financing | 10% | 50% | 43% | 11% |
| Current Ratio | 2.81% | 2.08% | 2.02% | 3.58% |
| Quick Ratio | 2.8% | 1.96% | 1.71% | 3.46% |
| Cash Position Ratio | 2.43% | 1.48% | 0.76% | 2.45% |
| Liquididy | 75% | 19% | 38% | 47% |
| Short-term ratios | AFMD | ABBV | AMGN | VRTX |
|---|---|---|---|---|
| Return on equity | -34.85% | -25.62% | 17.94% | 7.79% |
| Return on assets | -11.48% | 3.26% | 3.67% | 5.71% |
| Return on sales | 0% | 31.22% | 37.5% | 35.86% |
| Return on invested capital | 41.75% | 8.14% | 7.17% | 27.86% |
| Profitability | 25% | 40% | 70% | 76% |
| Total debt ratio | 66.85% | 105.33% | 83.42% | 27.67% |
| Debt ratio change over time | 0.6% | -23.44% | 9.66% | 1.33% |
| Dept financing | 17% | 25% | 45% | 10% |
| Current Ratio | 2.81% | 2.08% | 2.02% | 3.58% |
| Quick Ratio | 2.8% | 1.96% | 1.71% | 3.46% |
| Cash Position Ratio | 2.43% | 1.48% | 0.76% | 2.45% |
| Liquididy | 65% | 44% | 34% | 75% |